Dysport® was approved by the U.S. Food and Drug Administration in April, 2009 for treatment of glabellar lines – commonly known as frown lines - Dysport® has a history of use in other countries since 1991. Although Dysport® is not a dermal filler, it is often used in combination with non-surgical facelifts, facial contouring, and liquid face lift procedures.
Dysport® is a simple, nonsurgical treatment that can temporarily relax moderate to severe frown lines and wrinkles between the brows in adults less than 65 years of age.
With nearly 11 million botulinum toxin procedures performed in the U.S., its popularity continues to skyrocket and is the leading non-surgical cosmetic medical procedure globally.1
Dysport® works by stopping the signal from the nerves to the muscles, ultimately resulting in a reduction of muscle activity and temporarily preventing contraction of the muscles that cause frown lines. Dysport® is a purified form of botulinum toxin that has been shown to deliver temporary improvement in moderate to severe frown lines. Treatments typically take 5-10 minutes, and there is little or no downtime after injection. Although results may vary after treatment – a few tiny injections – within days there is typically a noticeable improvement in moderate to severe frown lines between the brows, which can last up to 4 months. It is recommended that you wait at least 90 days between Dysport® treatments.
Plastic surgeons, dermatologists and other physicians who use Dysport® employ it for wrinkle and line correction in other areas that include forehead wrinkles, lines across the top of the nose (bunny lines), lines and wrinkles around the mouth (marionette lines), smile lines and lines around the lips (smoker’s lines).
It is important to choose a skilled injector – someone who has the experience and training to recommend a facial rejuvenation treatment and provide natural-looking results. In the hands of an experienced injector, Dysport® can be used in concert with dermal fillers to produce even more dramatic results by lifting facial features and contouring of the face, often referred to as a liquid face lift or non surgical face lift. Using Dysport® to relax the depressor muscles allows the levators to gain control, producing a subtle lift in the treated area.
Dysport® has a history of therapeutic use since 1991 to treat patients with cervical dystonia. It was approved for aesthetic use outside of the U.S. in 2001, and is used in over 36 countries. In 2004, Dysport® was studied for safety in more than 2400 U.S. aesthetic patients, and received U.S. FDA approval in 2009 for the temporary improvement in the appearance of moderate to severe glabellar lines in adult patients less than 65 years of age.
Since Dysport® is injected with tiny needles and the procedure is so quick, physicians do not usually numb the area being treated. However, in sensitive areas such as around the lips, some healthcare professionals may apply topical anesthesia just prior to treatment. A Dysport® treatment typically takes just a few minutes to inject the fluid into the targeted area with fine-gauge needles. Within days, most patients will notice improvement in moderate to severe facial lines.
As the cosmetic medical industry continues to evolve, leading physicians in the U.S. now combine Dysport® with other aesthetic procedures such as dermal fillers and laser therapy, resulting in improved outcome, lower cost and maximum effectiveness for their patients. Using Dysport® in the combination therapy, the reduced muscle movement in targeted areas helps to slow the dissipation of dermal fillers and improve dermal filler endurance.
To maintain the effects gained by Dysport® treatment, it is usually recommended that the patient return for maintenance treatments every three to five months – depending on individual results, the physician technique, and the area to be treated. Patients may be able to reduce the amount of Dysport® required for each treatment by scheduling regular maintenance visits to their physician when they begin to see or feel excess movement in the treated area.
Dysport® is not recommended for individuals that are allergic to cow’s milk protein, have had an allergic reaction to any other botulinum toxin product, such as Myobloc or BOTOX®, or have a skin infection around the area to be injected. Dysport® may not be right for you if you have had surgical changes to your face, very weak muscles in the treatment area, your face looks very different from side to side, the injection site is inflamed, you have droopy eyelids or sagging eyelid folds, deep facial scars, thick oily skin, or if your wrinkles can’t be smoothed by spreading them apart. (2) Consult your physician for a complete list of side effects and to determine if Dysport® is right for you.
(Related topics: Wrinkle Correction - Facial Contouring - Dysport® or Dermal Filler -
How to Extend Results -
Physician Selection Tips -
Find a Physician -
What are the Risks -
1 Source: American Society of Plastic Surgeons and Allergan, Inc.
2 Source: Medicis Aesthetics Inc.
BOTOX® is a registered trademark of Allergan, Inc.
W. Grant Stevens MD FACS, Marina Del Rey, CA ~ Yvette Suarez MD, Wesley Chapel, FL
Stephen Mandy M.D., Miami Beach, FL
The Dysport® trademark is used under license by Medicis Aesthetics Inc.